Annual report pursuant to Section 13 and 15(d)

Note 14 - Stockholders' Equity (Tables)

v3.22.0.1
Note 14 - Stockholders' Equity (Tables)
12 Months Ended
Nov. 30, 2021
Notes Tables  
Schedule of Warrants Valuation Assumptions [Table Text Block]
 

2020

 

Risk free rate

  0.35 1.57%

 

Expected dividends

    0%  

 

Expected volatility

  98.28 109.93%

 

Expected life (in years)

  3.54 3.77  

Market price of the Company's common stock on date of grant

    $2.50    

Exercise price

    $2.50    
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]
           

Weighted-Average

 
   

Number of

   

Exercise

 
   

Warrants

    Price  
                 

Outstanding, November 30, 2019

    4,578,722       2.20  

Granted

    214,684       2.50  

Exercised

    (4,207,667

)

    (2.10

)

Outstanding, November 30, 2020

    585,739       2.40  

Granted

           

Exercised

    (585,739

)

    (2.40

)

Outstanding, November 30, 2021

           
                 

Exercisable, November 30, 2021

           

Exercisable, November 30, 2020

    585,739       2.40  
   

2021

   

2020

 
   

(years)

   

(years)

 

Total outstanding warrants

          2.82  

Total exercisable warrants

          2.82